deListed Australia
 
SEARCH LISTED OR DELISTED COMPANY
Any AUS or NZ company

Browse Australian delisted companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse terminated Australian managed funds

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
SEARCH PRIVATE COMPANY
SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

VPCL LTD (ASX.VPC)

ASX Announcements (courtesy of ASX)

2018201920202021

ASX, Legal & CGT Status

SHARE PRICES

(updated at weekends)
2018 2020 2021   ALL
Former (or subsequent) names
CompanyFROMTO
HEALTH HOUSE INTERNATIONAL LIMITED24/03/2021
VPCL LTD01/10/201824/03/2021
VELPIC LIMITED02/10/201501/10/2018
INTERNATIONAL COAL LIMITED02/10/2015
Shareholder links

 

REGISTRY:
Link Market Services Brisbane
Level 21, 10 Eagle Street Brisbane QLD 4000
Tel : +61 7 3320 2200 or 1300 554 474
Fax : +61 2 9287 0303
RegistryWebsite RegistryEmail

Company details
ISIN: AU000000VPC3
Address: 36/38 Manchester Lane, Melbourne
Tel:  1800 463 828 Fax: 08 6166 0261

Date first listed: 28/07/2011

Sector: Energy
Industry Group: XEJ
Activities: Coal exploration

name changed to Health House International Limited

24/03/2021

The company provides an update on the proposed issue of securitites.

19/03/2021

The company has completed the acquisition of Health House Holdings, issuing 115,298,743 shares in the company to the Health House vendors as consideration for the acquisition. The company has today issued 17,500,000 shares to subscribers under the Public Offer, with holding statements to be dispatched next week.

19/03/2021

The company has received conditional approval for the reinstatement of its securities to the official list of ASX subject to the satisfaction of certain conditions precedent. VPCL expects to complete the acquisition of Health Hosue Holdings Limited on 19 March 2021.

17/03/2021

The Company has decided to rely on ASIC Corporations (Amendment) Instrument 2020/1080 to extend the lodgement deadline for its audited half year accounts and other documents required to be lodged with ASIC under section 320 of the Corporations Act. As required under the conditions of the class relief granted by the ASX, the Company has today lodged its Appendix 4D and unaudited accounts with the ASX.

01/03/2021

The company lodges an Appendix 4D.

01/03/2021

The company lodges its Unaudited Half Year Reports.

01/03/2021

The Public Offer to raise up to $3,500,000 has been closed early due to significant demand and is now fully subscribed as of Monday the 8th of February 2021.

08/02/2021

The company releases the results of its meeting.

29/01/2021

The company lodges its Appendix 4C - quarterly.

29/01/2021

The company provides an update to the consolidation of its securities with an update on the scrip fraction rounding. Fractions of 0.5 or more are rounded up.

22/01/2021

The company releases a notice of consolidation of securities. Shareholders will get 1 share for every 50 presently owned.

21/01/2021

The company issues a prospectus for the offer of up to 17.5 million shares at an issue price of 0.20 each to raise up to $3,500,000 (before costs).

21/01/2021

The company's AGM will be held at the offices of Blackwall Legal, Level 26, 140 St Georges Terrace Perth WA on Friday, 29 January 2021 at 11.00am WST.

30/12/2020

The company releases a notice of Proposed issue of Securities - VPC.

24/11/2020

VPC signs binding heads of agreement to acquire leading international medicinal cannabis distribution business, Health House Holdings. HHH is a revenue generating exporter, importer and distributer of medicinal cannabis and pharmaceutical products across Australia and the UK. HHH operates two wholly owned subsidiaries, Health House International (Aus) and Health House Pharma (UK). Distribution agreements in place with leading GMP certified medicinal cannabis manufacturers and suppliers including, Aurora/Cannimed, Little Green Pharma, MGC Pharmaceuticals, Ananda Hemp, Satipharm, Zelira Therapeutics, IX Biopharma and HAPA. HHH generated group revenues of approximately A$6.5 million in FY20. CPS Capital engaged to lead manage a capital raising of $2.0 million.

24/11/2020

The company lodges its Appendix 4C - quarterly.

30/10/2020

The company releases its Appendix 4G and Corporate Governance Statement.

01/10/2020

The company lodges its Annual Report.

01/10/2020

The company lodges its Preliminary Final Report.

31/08/2020

The company lodges its Appendix 4C and Quarterly Report.

31/07/2020

The company lodges its Appendix 4C and Quarterly Report.

30/04/2020

The company lodges its Half Yearly Report and Accounts.

28/02/2020

The company lodges its Appendix 4C and Quarterly Report.

31/01/2020

The company releases its constitution.

29/11/2019

The company releases the results of its meeting.

29/11/2019

114,963,777 options exercisable at $0.02 each will expire on 30 November 2019.

27/11/2019

The company lodges its Appendix 4C and Quarterly Report.

31/10/2019

The company's AGM will be held at 10:00 am (Melbourne time) on 29 November 2019 at Unit 36 28 Manchester Lane MELBOURNE VICTORIA 3000.

25/10/2019

VPCL is pleased to confirm it has received payment of the $2.05m for sale of the Velpic business.

17/10/2019

The company has received confirmation from Damstra that it has completed its capital raising and is in a position to complete the one-off payment of the deferred consideration of $2.05 million referred to in the 31 July 2019 announcement relating to the sale of the company's LMS business to Damstra in 2018. Under the terms agreed by the Company and Damstra, this one-off payment was to be made by 15 October 2019, otherwise an interest component was to be paid by Damstra. Damstra has requested, and the company has agreed, to extend the payment date out to 18 October 2019 without any interest component being charged in order for Damstra to complete its final processes following its capital raising and make this payment. The company expects that Damstra will complete this transaction by making payment of the amount of $2.05 million to the company on or before 18 October 2019.

30/09/2019

The company lodges its Annual Report to shareholders.

30/09/2019

The company releases its Appendix 4G.

30/09/2019

The company lodges its Preliminary Final Report.

30/08/2019

In preparing for the upcoming audit, the Board and the external accountants have identified that the calculation of the NPV and associated interest reported in the financial accounts at 31 December 2018 was incorrect and not picked up during the review process. This has resulted in the receivables at 31 December 2018 in the Consolidated Statement of Financial Position to be understated, gain from discontinued operations to be understated and interest revenue in the Statement of Profit and Loss to be overstated. The adjustment to the NPV and interest in respect to this adjustment are non-cash related.

23/08/2019

The company lodges its App 4C & Quarterly Report.

31/07/2019

An agreement has been reached with Damstra to settle the deferred component of the sale of the LMS business in a single lump sum payment. Damstra is required to pay 3.5 times the total annual revenue earned by Damstra from all contracts that were assigned to Damstra over the three years after settlement up to a total payment of $2.8m. To date the maximum outstanding consideration is circa $2.3m. VPC and Damstra entered into an agreement to potentially bring forward the deferred consideration by the payment of a lump sum of $2.05m payable on 15 October 2019.

31/07/2019

The company lodges its App 4C & Quarterly Report.

30/04/2019

The company lodges its Half Yearly Report and Accounts.

28/02/2019

The company lodges its App 4C & Quarterly Report.

31/01/2019

The securities of VPCL Limited will remain suspended in accordance with Listing Rule 17.3 until VPC is able to demonstrate compliance with Listing Rule 12.1 of the Listing Rules or until the Company has complied with Chapters 1 and 2 of the Listing Rules in accordance with Listing Rule 11.1.3.

13/12/2018

VPC is pleased to announce a strategic investment of $500,000 to acquire a minority interest (5.21%) in alternative lender and new Australian financial technology company, Lumi, as part of Limi's recent capital raising of $31.5million (comprising of $25 million in debt and $6.5 million in equity). The Company is now pleased to advise that the various shareholders of NowForce, of which the Company is only a minor holder, have accepted an offer for all of their respective interests in NowForce. The Company is now expected to imminently receive an initial payment of approximately $1.245 million (US$895,900) for its interest in NowForce with a further approximate $219,000 (US$158,000) held in an escrow account for 18 months from completion. The Company now currently has approximately $1.007 million in cash at bank, with a further $1.245 million expected to be received imminently once initial funds are received from the NowForce sale, taking the Company's cash to $2.252 million. The Company continues to investigate opportunities for new investment or acquisition following the disposal of the Company's main business undertaking to Damstra Technology.

13/12/2018

The company releases the results of its AGM.

27/11/2018

The securities of VPCL Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of VPC, pending the release of an announcement regarding a market update on its recent activities.

19/11/2018

name changed from Velpic Limited

01/10/2018
View ASX Announcements (courtesy of ASX)

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates
Post your comments here
Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    loading Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNATURENUMBERPRICEAMOUNT
    21/12/2016Russell Francis1,000,000$0.017$17,356
    18/03/2015John LesterOn market100,000$0.020$2,011
    18/03/2015John LesterOn market100,000$0.020$2,011
    22/12/2014John LesterOn market51,000$0.020$1,020
    17/12/2014Hugh DaiOn market340,000$0.021$7,300

    Click here for the last 20 transactions all companies

    Directors & Executives (current)
    NAMETITLEDATE OF APPT
    David WheelerExecutive Chairman02/04/2020
    Leanne GrahamNon Exec Chairman10/10/2015
    Christopher MewsNon Exec Director13/07/2018
    Michael RannNon Exec Director19/03/2021
    Tim SlateCompany Secretary

    Date of first appointment, title may have changed.

    SPECIAL NOTE: During May 2024 we are working to remove duplications in the Company Secretary role.

    Directors & Executives (former)
    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Justin KlintbergNon Exec Director03/04/201802/04/2020
    Rhonda RobatiExecutive01/01/201717/08/2018
    Russell FrancisCEO22/10/201513/07/2018
    Daniel RohrNon Exec Director10/12/201503/04/2018
    Harry KarelisNon Exec Director19/10/201403/04/2018
    Patrick ConnellExecutive Director22/10/201525/10/2016
    Glen MooraExecutive Director22/10/201525/10/2016
    John LesterNon Exec Chairman08/02/201130/10/2015
    Noel HalgreenNon Exec Director16/11/201222/10/2015
    Hugh DaiExecutive Director, CEO08/02/201122/10/2015
    Glenn SimpsonCEO16/01/201306/06/2014
    David RoundCFO21/11/201101/03/2013

    Date of first appointment, title may have changed.